Bioscience Animal Health PCL (BKK:BIS)
Thailand
· Delayed Price · Currency is THB 2.520
0.00 (0.00%)
Jun 13, 2025, 4:04 PM ICT
BKK:BIS Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Operating Revenue | 2,329 | 2,324 | 2,412 | 2,194 | 1,975 | 1,760 | Upgrade
|
| Other Revenue | 50.82 | 50.82 | 14.52 | 18.86 | 11.48 | 21.51 | Upgrade
|
| Revenue | 2,380 | 2,374 | 2,427 | 2,213 | 1,986 | 1,782 | Upgrade
|
| Revenue Growth (YoY) | -3.26% | -2.16% | 9.65% | 11.43% | 11.47% | -5.26% | Upgrade
|
| Cost of Revenue | 1,975 | 1,978 | 2,080 | 1,877 | 1,628 | 1,442 | Upgrade
|
| Gross Profit | 404.99 | 396.56 | 347.32 | 335.81 | 358.34 | 340.19 | Upgrade
|
| Selling, General & Admin | 293.84 | 291.02 | 279.03 | 260.17 | 262.37 | 251.89 | Upgrade
|
| Other Operating Expenses | 9.19 | 10.71 | - | - | - | - | Upgrade
|
| Operating Expenses | 303.03 | 301.72 | 279.03 | 260.17 | 262.37 | 261.71 | Upgrade
|
| Operating Income | 101.96 | 94.84 | 68.29 | 75.63 | 95.97 | 78.47 | Upgrade
|
| Interest Expense | -2.66 | -2.63 | -1.89 | -6.27 | -9.94 | -9.07 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 1.16 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | 0.3 | 3.37 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.7 | Upgrade
|
| EBT Excluding Unusual Items | 99.3 | 92.21 | 66.4 | 69.37 | 86.33 | 74.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 0.27 | -1.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 6.4 | - | - | Upgrade
|
| Pretax Income | 99.3 | 92.21 | 66.4 | 75.77 | 86.6 | 73.14 | Upgrade
|
| Income Tax Expense | 22.11 | 20.55 | 13.52 | 16.09 | 17.97 | 18.7 | Upgrade
|
| Earnings From Continuing Operations | 77.18 | 71.66 | 52.88 | 59.67 | 68.62 | 54.45 | Upgrade
|
| Minority Interest in Earnings | -7 | -6.62 | -2.18 | -3.76 | 3.78 | 7.79 | Upgrade
|
| Net Income | 70.19 | 65.04 | 50.71 | 55.92 | 72.4 | 62.23 | Upgrade
|
| Net Income to Common | 70.19 | 65.04 | 50.71 | 55.92 | 72.4 | 62.23 | Upgrade
|
| Net Income Growth | 21.52% | 28.27% | -9.32% | -22.77% | 16.34% | 110.70% | Upgrade
|
| Shares Outstanding (Basic) | 314 | 314 | 314 | 284 | 220 | 176 | Upgrade
|
| Shares Outstanding (Diluted) | 314 | 314 | 314 | 284 | 220 | 176 | Upgrade
|
| Shares Change (YoY) | - | - | 10.71% | 28.91% | 25.24% | 9.79% | Upgrade
|
| EPS (Basic) | 0.22 | 0.21 | 0.16 | 0.20 | 0.33 | 0.35 | Upgrade
|
| EPS (Diluted) | 0.22 | 0.21 | 0.16 | 0.20 | 0.33 | 0.35 | Upgrade
|
| EPS Growth | 21.52% | 28.27% | -18.09% | -40.09% | -7.11% | 91.92% | Upgrade
|
| Free Cash Flow | 152.09 | 98.5 | -28.66 | -47.25 | 18.49 | -1.86 | Upgrade
|
| Free Cash Flow Per Share | 0.48 | 0.31 | -0.09 | -0.17 | 0.08 | -0.01 | Upgrade
|
| Dividend Per Share | 0.140 | 0.140 | 0.110 | 0.122 | 0.410 | 0.138 | Upgrade
|
| Dividend Growth | 27.27% | 27.27% | -10.20% | -70.12% | 198.18% | -78.28% | Upgrade
|
| Gross Margin | 17.02% | 16.70% | 14.31% | 15.17% | 18.04% | 19.09% | Upgrade
|
| Operating Margin | 4.28% | 3.99% | 2.81% | 3.42% | 4.83% | 4.40% | Upgrade
|
| Profit Margin | 2.95% | 2.74% | 2.09% | 2.53% | 3.65% | 3.49% | Upgrade
|
| Free Cash Flow Margin | 6.39% | 4.15% | -1.18% | -2.14% | 0.93% | -0.10% | Upgrade
|
| EBITDA | 116.17 | 107.79 | 80.56 | 87.92 | 108.41 | 90.45 | Upgrade
|
| EBITDA Margin | 4.88% | 4.54% | 3.32% | 3.97% | 5.46% | 5.08% | Upgrade
|
| D&A For EBITDA | 14.22 | 12.95 | 12.27 | 12.29 | 12.44 | 11.98 | Upgrade
|
| EBIT | 101.96 | 94.84 | 68.29 | 75.63 | 95.97 | 78.47 | Upgrade
|
| EBIT Margin | 4.28% | 3.99% | 2.81% | 3.42% | 4.83% | 4.40% | Upgrade
|
| Effective Tax Rate | 22.27% | 22.29% | 20.36% | 21.24% | 20.75% | 25.56% | Upgrade
|
| Revenue as Reported | 2,385 | 2,374 | 2,427 | 2,220 | 1,987 | 1,784 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.